News

Wellington invests in iOmx €40m Series A

Details

iOmx Therapeutics raises EUR 40 million in Series A round led by MPM Capital, Sofinnova Partners, Wellington Partners and Merck Ventures 

Invendo receives FDA clearance for Invendoscopy E200 System

Details

invendo medical Announces FDA Clearance of the invendoscopy E200 System –Including the First and Only Sterile, Single-use Endoscope For Colonoscopies 

Themis Zika Vaccine Developement receives 1 Mio GBP Boost

Details

Themis Bioscience: Zika Vaccine Development Receives Big Boost by Innovate UK 

  1. Rigontec extends Series A with additional €15 million
  2. Evolva collaborates with US Navy
  3. Themis announces exclusive license with Institut Pasteur and Zika vaccine
  4. Resminostat boosts cancer immunotherapy
© Wellington Partners, 2021.